CHARLOTTE, N.C., June 08, 2017 -- Barings, one of the world’s leading asset management firms, announced today that it served as lead agent and provided senior credit facilities to support TA Associates’ investment in Biocomposites, a manufacturer and marketer of calcium compound biologics.
Biocomposites is singularly focused on the development of innovative calcium compounds for surgical use. Their bone graft matrices can be used in the presence of infection for regenerating bone and managing dead space in a range of orthopedic procedures. Biocomposites sells directly to hospitals and through independent distributors, with the United States representing its largest market. Research, manufacturing and distribution is handled in-house at the company’s headquarters in Keele, UK. Sales representative offices are also maintained in Wilmington, North Carolina and Shanghai, China.
About TA Associates
TA Associates is one of the largest and most experienced global growth private equity firms. The firm has invested in more than 450 companies around the world and has raised $24 billion in capital. With offices in Boston, Menlo Park, London, Mumbai and Hong Kong, TA Associates leads buyouts and minority recapitalizations of profitable growth companies in the technology, financial services, business services, healthcare and consumer industries. More information about TA Associates can be found at www.ta.com.
About Barings LLC
Barings is a $280 billion* global asset management firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. A member of the MassMutual Financial Group, Barings maintains a strong global presence with over 1,700 employees and 600 investment professionals across 41 offices in 17 countries. Learn more at www.barings.com.
*As of March 31, 2017
17/420
Contact: Brian Whelan, Barings, 704.805.7244, [email protected]


Bill Ackman Eyes New Fund to Bet Against Market Complacency
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 



